Home

James E. Levine

CIK 1463151 · Chief Financial Officer · last filed 2026-06-23

James E. Levine is a Chief Financial Officer who has filed 29 SEC Form 4 insider transactions across 4 companies since 2009. The most recent filing, for KZIA, was dated Jun 23, 2026. Across all open-market trades the lifetime net is +$757.9K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $102.5K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$102.5K

Companies

4

Total Filings

29

Lifetime Open-Market Net

$757.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KZIA Chief Financial Officer — $12.69 — $0 1 2026-06-23
CRDF Chief Financial Officer 125,316 $0.82 $102.5K $277.4K 8 2025-03-13
Cidara Therapeutics, Inc. (CDTX) Delisted Chief Financial Officer 5,990 $221.38 $1.33M $215.2K 7 2021-03-19
VERENIUM CORP (VRNM) Delisted President & CEO 109,166 — — $265.2K 12 2013-08-02

Recent Filings

29 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-23 KZIA Grant (A) — $0 EDGAR
2025-03-13 CRDF Grant (A) — $0 EDGAR
2024-12-18 CRDF Buy (P) +7,716 $36.7K EDGAR
2024-03-07 CRDF Grant (A) — $0 EDGAR
2023-03-16 CRDF Grant (A) — $0 EDGAR
2022-09-19 CRDF Buy (P) +30,000 $46.7K EDGAR
2022-03-10 CRDF Grant (A) — $0 EDGAR
2021-09-13 CRDF Buy (P) +30,000 $194.0K EDGAR
2021-07-12 CRDF Grant (A) — $0 EDGAR
2021-03-19 Cidara Therapeutics, Inc. (CDTX) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 29
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.